AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System

Overview of attention for article published in Frontiers in Neurology, April 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 34 Mendeley

Summary X

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 18,157 followers.

@antonioregalado @pdhsu For recombinant AAV a single injection in the muscle can provide life long production of antibody - an approach called vectored imuniprophlaxis (VIP) - read more here https://t.co/FuRnmCmPVa

03 Jan 2024

Reply Repost Favourite

AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System https://t.co/cOxnfViTri https://t.co/spmg3arD9F

10 May 2022

Reply Repost Favourite

RT @bbbpapers: AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System https://t.co/IBoQufK4eu

06 May 2022

Reply Repost Favourite

RT @bbbpapers: AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System https://t.co/IBoQufK4eu

03 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.